AVITA Medical Reports First Quarter Fiscal 2020 Financial Results and Company Update
Avita Medical, Inc. (RCEL)
Company Research
Source: Business Wire
U.S. RECELL® System product sales of A$4.6M for fiscal first quarter, 60% growth quarter-over-quarterOver half of all U.S. burn centers and surgeons trained on RECELL System VALENCIA, Calif. & MELBOURNE, Australia--(BUSINESS WIRE)--AVITA Medical (ASX: AVH, NASDAQ: RCEL), a regenerative medicine company with a technology platform positioned to address unmet medical needs in therapeutic skin restoration, reported financial results for the fiscal first quarter ended 30 September 2019 today in its Appendix 4C - Quarterly Cash Flow Report filed with the ASX.U.S. Commercial Sales of RECELL® SystemThe RECELL System has been actively promoted for nine months in the United States following approval by the U.S. Food and Drug Administration (FDA) on 20 September 2018, and the full nationwide commercial launch in January 2019. Product sales and other revenues for the first quarter ended 30 September 2019 were as follows (unaudited): Three Months Ended(In thousands of AUD)30 September 2019 2018
Show less
Read more
Impact Snapshot
Event Time:
RCEL
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
RCEL alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
RCEL alerts
High impacting Avita Medical, Inc. news events
Weekly update
A roundup of the hottest topics
RCEL
News
- AVITA Medical Announces FDA 510(k) Clearance for Cohealyx, Expanding its Addressable Market [Yahoo! Finance]Yahoo! Finance
- AVITA Medical Announces FDA 510(k) Clearance for Cohealyx, Expanding its Addressable MarketGlobeNewswire
- AVITA Medical to Present at the 43rd Annual J.P. Morgan Healthcare ConferenceGlobeNewswire
- miraDry Launches Female Leadership Exchange (FLEX) Initiative: Empowering Women in Medical Technology through Advocacy, Innovation, and Strategic Leadership [Yahoo! Finance]Yahoo! Finance
- AVITA Medical to Present at the Piper Sandler 36?? Annual Healthcare ConferenceGlobeNewswire
RCEL
Earnings
- 11/7/24 - Miss
RCEL
Sec Filings
- 12/5/24 - Form 4
- 11/7/24 - Form 10-Q
- 11/7/24 - Form 8-K
- RCEL's page on the SEC website